• Radiaton Drug combos

Some Radiaton-Drug combos just make side effects worse

Ottobre 2nd, 2019|

Taking certain cancer-fighting drugs while undergoing radiation therapy may not increase survival, but could instead increase side effects, according new study. The drugs may still benefit patients who aren’t undergoing radiation therapy, say the researchers. In a meta-analysis, researchers find [...]

  • Up and down the ladder

Up and down the ladder: The latest comings and goings

Agosto 23rd, 2019|

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. [...]

  • personalize radiation treatment

Researchers develop model to personalize radiation treatment

Agosto 22nd, 2019|

A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same personalized strategy has not translated to radiation [...]

  • Patient preferences explored in multiple myeloma treatment

Patient preferences explored in multiple myeloma treatment

Agosto 20th, 2019|

(HealthDay)—An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment satisfaction in patients with relapsed or refractory multiple myeloma (RRMM), but receiving medication orally is linked to higher satisfaction, according to a study published online [...]

Drug May Aid People With Advanced Thyroid Cancer

Agosto 17th, 2019|

MONDAY, Aug. 13 (HealthDay News) -- A new study shows that the chemotherapy drug vandetanib (Caprelsa) may extend life a bit for some thyroid cancer patients. The results of phase 2 trials showed that patients taking the drug lived for 11 months without the cancer progressing, [...]

How Amgen plans to BiTE into CAR-T’s hype

Agosto 16th, 2019|

While personalized CAR-T cancer therapies make headlines in biotech, Amgen has been betting big on another tumor-killing approach with, yes, another acronym: BiTEs. The trademarked term stands for a bi-specific T-cell engager — an antibody that can grab both immune cells [...]

Study finds lack of racial diversity in cancer drug clinical trials

Agosto 15th, 2019|

New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study—conducted by researchers from UBC, the University of Texas MD Anderson Cancer Center, the Fred Hutchinson Cancer Center [...]

New drug shows encouraging survival in pancreatic cancer

Agosto 14th, 2019|

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. A phase 1 clinical trial looked at AZD1775, an inhibitor designed to block an enzyme called [...]

More Evidence Tamoxifen, Other Meds Help Limit Breast Cancer’s Spread

Giugno 2nd, 2016|

THURSDAY, Oct. 6, 2016 (HealthDay News) -- Treatment with tamoxifen or another class of drugs called aromatase inhibitors does cut breast cancer patients' risk of developing cancer in their other breast, a new study finds. Some breast cancers rely on estrogen to help them grow, and drugs like tamoxifen or the aromatase inhibitors (which [...]

1 in 3 Women Survive Ovarian Cancer a Decade or More: Study

Agosto 11th, 2015|

TUESDAY, Aug. 11, 2015 (HealthDay News) -- Ovarian cancer has a reputation as a swift killer that's often detected at a late stage, but a new study suggests that up to one-third of the women who are handed the grim diagnosis survive [...]

Postmenopausal Women With Breast Cancer Face Joint Issues

Agosto 12th, 2008|

TUESDAY, Aug. 12 (HealthDay News) — Postmenopausal women with breast cancer who are receiving endocrine treatment may be at increased risk of joint issues, including arthritis, a new study finds. British researchers publishing in the September issue of The Lancet Oncology, found that previous use of hormone replacement [...]